Hemovent GmbH

Hemovent GmbH is a German medical technology company based in Aachen, founded in 2013. The company specializes in advanced extracorporeal life support (ECLS) systems, particularly extracorporeal membrane oxygenation (ECMO) devices. Hemovent is dedicated to enhancing ECMO technology by creating innovative, portable, and user-friendly heart and lung support systems that prioritize safety and simplicity. The flagship product, the MOBYBOX®, is the world's smallest fully self-contained portable ECMO device, designed for both heart and lung support. Weighing less than 2 kg and capable of fitting in a backpack, the MOBYBOX® operates pneumatically without the need for external power or software. This design allows for mobility and ease of use in critical care settings, enabling ECMO support outside traditional hospital environments. Hemovent's products are aimed at hospitals and healthcare providers managing patients with severe respiratory and cardiac failure, with a focus on improving patient outcomes through effective and cost-efficient ECMO therapy. In 2021, Hemovent became a wholly-owned subsidiary of MicroPort Scientific Corporation, which supports the global expansion of its innovative ECMO technology. The company is ISO EN 13485:2016 certified, reflecting its commitment to quality in medical device production.

• Employees 17
• Founded 2013
• Total Funding $13528904